# Idecabtagene vicleucel (ide-cel; bb2121), a BCMA-targeted CAR T-cell therapy, in patients with relapsed and refractory multiple myeloma (RRMM): Initial KarMMa results.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/idecabtagene-vicleucel-ide-cel-bb2121-a-bcma-targeted-car-t-cell-therapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nikhil C. Munshi,Larry D. Anderson,Nina Shah,Sundar Jagannath,Jesús G. Berdeja,Sagar Lonial,Noopur Raje,David S. Siegel,Yi Lin,Albert Oriol,Philippe Moreau,Ibrahim Yakoub‐Agha,Michel Delforge,Fabio Petrocca,Jamie N. Connarn,Payal Patel,Liping Huang,Timothy Campbell,Kristen Hege,Jesús F. San Miguel,on behalf of the KarMMa Study Investigators |
| Citations | 123 |
| DOI | 10.1200/jco.2020.38.15_suppl.8503 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3032142108 |
| Type | conference-abstract |
| Year | 2020 |

## Paper authors

- [Timothy Campbell](https://scholariq.org/researchers/timothy-campbell/)
- [Michel Delforge](https://scholariq.org/researchers/michel-delforge/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.